173 related articles for article (PubMed ID: 26035378)
41. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
42. Detection of epigenetic aberrations in the development of hepatocellular carcinoma.
Zhang Y
Methods Mol Biol; 2015; 1238():709-31. PubMed ID: 25421688
[TBL] [Abstract][Full Text] [Related]
43. SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.
Jin T; Fu J; Feng XJ; Wang SM; Huang X; Zhu MH; Zhang SH
Cell Biol Int; 2013 Sep; 37(9):929-39. PubMed ID: 23589395
[TBL] [Abstract][Full Text] [Related]
44. Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo.
Li CH; Wang YJ; Dong W; Xiang S; Liang HF; Wang HY; Dong HH; Chen L; Chen XP
Cancer Lett; 2011 Dec; 311(1):1-10. PubMed ID: 21821357
[TBL] [Abstract][Full Text] [Related]
45. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P
Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.
Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X
Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421
[TBL] [Abstract][Full Text] [Related]
47. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
48. Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cells.
Zhou R; Liu M; Liang X; Su M; Li R
Environ Toxicol Pharmacol; 2019 Oct; 71():103225. PubMed ID: 31376682
[TBL] [Abstract][Full Text] [Related]
49. Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.
Yim SY; Shim JJ; Shin JH; Jeong YS; Kang SH; Kim SB; Eun YG; Lee DJ; Conner EA; Factor VM; Moore DD; Johnson RL; Thorgeirsson SS; Lee JS
Mol Cancer Res; 2018 Nov; 16(11):1713-1723. PubMed ID: 30082483
[TBL] [Abstract][Full Text] [Related]
50. Hepatocellular carcinoma--a model of human cancer: clinico-pathological features, etiology and pathogenesis.
Nayak NC
Indian J Pathol Microbiol; 2003 Jan; 46(1):1-16. PubMed ID: 15027710
[TBL] [Abstract][Full Text] [Related]
51. Male-specific hepatitis B virus large surface protein variant W4P potentiates tumorigenicity and induces gender disparity.
Lee SA; Kim H; Won YS; Seok SH; Na Y; Shin HB; Inn KS; Kim BJ
Mol Cancer; 2015 Feb; 14(1):23. PubMed ID: 25645622
[TBL] [Abstract][Full Text] [Related]
52. Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks.
Radaeva S; Li Y; Hacker HJ; Burger V; Kopp-Schneider A; Bannasch P
J Hepatol; 2000 Oct; 33(4):580-600. PubMed ID: 11059863
[TBL] [Abstract][Full Text] [Related]
53. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma.
Lin YT; Jeng LB; Chan WL; Su IJ; Teng CF
Viruses; 2021 May; 13(5):. PubMed ID: 34066744
[TBL] [Abstract][Full Text] [Related]
55. Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.
Chiu AP; Tschida BR; Lo LH; Moriarity BS; Rowlands DK; Largaespada DA; Keng VW
World J Gastroenterol; 2015 Nov; 21(42):12157-70. PubMed ID: 26576100
[TBL] [Abstract][Full Text] [Related]
56. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
57. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
58. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice.
Huang SN; Chisari FV
Hepatology; 1995 Mar; 21(3):620-6. PubMed ID: 7875658
[TBL] [Abstract][Full Text] [Related]
59. Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection.
Yaligar J; Teoh WW; Othman R; Verma SK; Phang BH; Lee SS; Wang WW; Toh HC; Gopalan V; Sabapathy K; Velan SS
Sci Rep; 2016 Feb; 6():20299. PubMed ID: 26831370
[TBL] [Abstract][Full Text] [Related]
60. The role of bone marrow-derived cells in the origin of liver cancer revealed by single-cell sequencing.
Chen L; Yi X; Guo P; Guo H; Chen Z; Hou C; Qi L; Wang Y; Li C; Liu P; Liu Y; Xu Y; Zhang N
Cancer Biol Med; 2020 Feb; 17(1):142-153. PubMed ID: 32296582
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
